Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2012 / Cilt: 58 - Sayı: 3

Fizik tedavi uygulanan diz osteoartritli hastalarda topikal glukozamin sülfat-kondroitin sülfatın etkinliği: Randomize çift kör plasebo kontrollü bir çalışma

The efficacy of topical glucosamine sulfate-chondroitin sulfate in knee osteoarthritis treated with physical therapy: A randomized, double-blind, placebo-controlled study

Pages
194–198
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Turk J Phys Med Re hab 2012;58:194-8.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine the efficacy of topical glucosamine on pain and functional status in patients receiving physical therapy for knee osteoarthritis (OA).
📊
Key Findings & Data:The first group consisted of 27 patients receiving physical therapy and topical glucosamine and the second group consisted of 22 patients receiving physical therapy and placebo, for 4 weeks.
💡
Conclusion & Impact:Turk J Phys Med Re hab 2012;58:194-8.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To determine the efficacy of topical glucosamine on pain and functional status in patients receiving physical therapy for knee osteoarthritis (OA). Materials and Methods: Forty-nine patients with knee OA were randomized into two groups. The first group consisted of 27 patients receiving physical therapy and topical glucosamine and the second group consisted of 22 patients receiving physical therapy and placebo, for 4 weeks. The patients and the physician were blinded to the treatment. The patients were evaluated before the treatment and at 1, 4, and 12 weeks. Demographic features, pain duration and radiological findings (Kellgren-Lawrence) were recorded; joint stiffness and physical function were evaluated by the Western Ontario and McMaster Osteoarthritis Index (WOMAC). Results: The WOMAC scores for pain, stiffness, and function were significantly improved in both groups at 1 and 4 weeks as compared to the pre-treatment period (P0.05). Conclusion: In this study, it was shown that topical glucosamine treatment combined with physical therapy in patients with knee OA had no superiority over placebo. Turk J Phys Med Re hab 2012;58:194-8.

Özet

Amaç: Fizik tedavi gören Diz Osteoartritli (OA) hastalarda, topikal glukozamin uygulamasının ağrı ve fonksiyonel durum üzerine etkinliğini ve güvenirliliğini belirlemek. Gereç ve Yöntem: Diz OA’lı 49 hasta yazı tura yöntemi ile randomize edilerek iki gruba ayrıldı. Birinci gruba fizik tedavi modaliteleri (FT) ve topikal glukozamin, ikinci gruba FT ve topikal plasebo ilaç 4 hafta boyunca uygulandı. Hastaları değerlendiren hekim ve hastalar kör idi. Hastalar tedavi öncesi, 1. hafta, 4. hafta ve 12. haftada değerlendirildi. Hastaların demografik özellikleri, ağrı süresi, radyolojik bulguları (Kellgren -Lawrence) kaydedildi; Western Ontario and McMaster Universities Arthritis Index (WOMAC) skalası ile ağrı, eklem sertliği ve fiziksel fonksiyonlar değerlendirildi. Bulgular: Her iki grupta WOMAC ağrı, tutukluk ve fonksiyon skorları birinci hafta ve dördüncü haftada tedavi öncesine göre anlamlı olarak düzelmişti (p0,05). Sonuç: Çalışmamızda fizik tedavi modaliteleri yanında topikal glukozamin uygulamasının plaseboya göre üstünlüğü bulunmamıştır. Türk Fiz T›p Re hab Derg 2012;58:194-8.

🔖

Cite This Article

ERHAN, B., BARDAK, A. N., SAVAŞ, F., ÜSTÜNEL, S. H., ISKA, G., KARAKOYUN, Z., GÜNDÜZ, B. (2022). Fizik tedavi uygulanan diz osteoartritli hastalarda topikal glukozamin sülfat-kondroitin sülfatın etkinliği: Randomize çift kör plasebo kontrollü bir çalışma. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 58 - Sayı: 3, 194–198. https://ajindex.com/articles/629354

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Benedek TG. A history of the understanding of cartilage. Osteoarthritis Cartilage 2006;14:203-9
  2. Gençosmanoglu BE, Eryavuz M, Dervişoğlu S. Effects of some nonsterodial anti-inflammatory drugs on articular cartilage of rats in an experimental model of osteoarthritis. Res Exp Med (Berl) 2001;200:215-26
  3. Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF. The prevalence of knee osteoarthritis in the elderly: The Framingham Osteoarthritis Study. Arthritis Rheum 1987;30:914-8
  4. Vanhoff J, Derlerck K, Geusens P. Prevalence of rheumatic diseases in a rheumatological outpatient practice. Ann Rheum Dis 2002;61:453-5
  5. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-55
  6. McAlindon TE, La Valley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000;283:1469-75. 7. da Camara CC, Dowless GV. Glucosamine sulfate for osteoarthritis. Ann Pharmacother 1998;32:580-7
  7. Bruyere O, Reginster JY. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Drugs Aging 2007;24:573-80
  8. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62
  9. Biggee BA, Blinn CM, McAlindon TE, Nuite M, Silbert JE. Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness. Ann Rheum Dis 2006;65:222-6
  10. Leeb BF, Schweitwer H, Montag K, Smolen JS. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol 2000;27:205-11
  11. Das A Jr, Hammad TA. Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage 2000;8:343-50
  12. Deal CL, Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am 1999;25:379-95
  13. Kellgren JH, Lawrence JS. Rad